35 days
Submission to first decision

Drugs promotes optimum pharmacotherapy by providing a programme of review and original research articles on the most important aspects of clinical pharmacology and therapeutics. The Journal includes:
Leading/current opinion articles providing an overview of contentious or emerging issues.
Definitive reviews of drugs and drug classes, and their place in disease management.
Therapy in Practice articles including recommendations for specific clinical situations.
High-quality, well designed, original clinical research.
Adis Drug Evaluations reviewing the properties and place in therapy of both newer and established drugs.
AdisInsight Reports summarising development at first global approval.
Additional enhanced features (including slide sets, videos and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Drugs may be accompanied by plain language summaries to assist readers in understanding important medical advances.
All manuscripts are subject to peer review by international experts. Letters to the editor are welcomed and will be considered for publication.

Editor (Adis International Limited, Auckland, New Zealand):
Dene Peters
Section Editors (Adis International Limited, Auckland, New Zealand):
Martin Chopra
Alison Fitches
Kathy Fraser
Rod McNab
Kate Palmer
Sue Pochon
Amitabh Prakash
David Williamson
Editorial Board:
P. Abrams, Bristol Urological Institute, Bristol, England
A. Antonelli, University of Pisa, Pisa, Italy
P.J. Barnes, National Heart and Lung Institute, London, England
W.R. Bowie, University of British Columbia, Vancouver, BC, Canada
M. Cazzola, University of Rome Tor Vergata, Rome, Italy
B.D. Cheson, Georgetown University Hospital, Washington, DC, USA
P.K. Coyle, Stony Brook University Medical Center, Stony Brook, NY, USA
R. Dawson, University of Cape Town Lung Institute, Cape Town, South Africa
L. de Angelis, Universita degli Studi di Trieste, Trieste, Italy
M. de Lima, Case Western Reserve University, Cleveland, OH, USA
B.G. Feagan, University of Western Ontario, London, Ontario, Canada
W.H. Frishman, New York Medical College, Valhalla, NY, USA
A.S. Galanopoulou, Albert Einstein College of Medicine, Bronx, NY, USA
B. Gallwitz, Eberhard-Karls-University, Tübingen, Germany
B.G. Gazzard, Chelsea & Westminster Hospital, London, England
A.H. Groll, Children’s University Hospital, Münster, Germany
J. Jankovic, Baylor College of Medicine, Houston, TX, USA
V. Jordan, Auckland University, Auckland, New Zealand
C. Katlama, Hôpital Pitié-Salpêtrière, Paris, France
W. Koizumi, Kitasato University, Kanagawa, Japan
A. Krentz, ProSciento, San Diego, CA, USA
M. Kuwana, Nippon Medical School Graduate School of Medicine, Tokyo, Japan
F. Locatelli, Alessandro Manzoni Hospital, Lecco, Italy
H. Lode, Charite Universitätsmedizin Berlin, Berlin, Germany
P.E. Lønning, University of Bergen, Bergen, Norway
A.P. MacGowan, Southmead Health Services NHS Trust, Bristol, England
G. Maconi, ‘Luigi Sacco’ University Hospital, Milan, Italy
H.I. Maibach, University of California San Francisco School of Medicine, San Francisco, CA, USA
G.S. Malhi, University of Sydney, Sydney, NSW, Australia
P.L. McCarthy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
S. Mercandante, University of Palermo, Palermo, Italy
F. Montorsi, Istituto Scientifico H. San Raffaele, Milan, Italy
A.D. Mooradian, University of Florida College of Medicine, Jacksonville, FL, USA
F.M. Muggia, NYU Cancer Institute, New York, NY, USA
R.L. Murphy, Northwestern University, Chicago, IL, USA
K.G. Naber, Technical University Munich, Straubing, Germany
S. Nattel, Montreal Heart Institute & Universite de Montreal, Montreal, QC, Canada
P. Patsalos, University College of London Institute of Neurology, London, England
E.G. Playford, Princess Alexandra Hospital, Brisbane, QLD, Australia
P.J. Pockros, Scripps Clinic, La Jolla, CA, USA
G. Poulakou, Athens National and Kapodistrian University, Athens, Greece
D. Price, University of Aberdeen, Aberdeen, Scotland
I.R. Raz, Hadassah Hebrew University Hospital, Jerusalem, Israel
J-Y. Reginster, University of Liege, Liege. Belgium
R. Rosell, Catalan Institute of Oncology, Barcelona, Spain
S.H. Roth, Arizona Research and Education, Phoenix, AZ, USA
D.H. Ryan, Pennington Biomedical Research Center, Baton Rouge, LA, USA
S.A. Schug, University of Western Australia, Perth, WA, Australia
D.L. Scott, Kings College London, London, England
R.W. Shafer, Stanford University School of Medicine, Stanford, CA, USA
L.P. Shulman, Feinberg School of Medicine of Northwestern University, Chicago, Ill, USA
K.S.M. Smalley, Moffitt Cancer Center & Research Institute, Tampa, FL, USA
T.M. Speight, Medicines Information Co. Ltd, Auckland, New Zealand
S.A. Spinler, Binghamton University, Binghamton, NY, USA
C. Stedman, Christchurch Public Hospital, Christchurch, New Zealand
M.W. Stewart, Mayo School of Medicine, Jacksonville, FL, USA
T. Torres, Centro Hospitalar Universitário do Porto, Porto, Portugal
J. Turnidge, Australian Commission for Safety and Quality in Health Care, Adelaide, SA, Australia
D. van Duin, University of North Carolina, Chapel Hill, NC, USA